Incidence of ventilator-associated pneumonia: Egyptian study

被引:8
|
作者
Elkolaly, Reham M. [1 ]
Bahr, Hoda M. [1 ]
El-Shafey, Basem, I [1 ]
Basuoni, Ahmed S. [2 ]
Elber, Eman H. [3 ]
机构
[1] Tanta Univ, Fac Med, Chest Dept, Tanta, Egypt
[2] Tanta Univ, Fac Med, Anaesthia Dept, Tanta, Egypt
[3] Tanta Univ Hosp, Chest Dept, Tanta, Egypt
关键词
hospital acquired pneumonia; intensive care unit; mechanical ventilation; ventilator-associated pneumonia; INTENSIVE-CARE-UNIT; RISK-FACTORS; SUSCEPTIBILITY; ETIOLOGY; ONSET;
D O I
10.4103/ejb.ejb_43_18
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background Despite different ICU admission causes, ventilator-associated pneumonia (VAP) is still a common cause of mortality and morbidity in intubated patients and impedes obvious progression in diagnostic modalities and management of these infections. Aim of study The aim of this study was to estimate VAP incidence in Tanta University Hospitals ICUs. Settings and design This was a crossover observational study. Patients and methods This was a one-year study (April 2015 to March 2016), including patients on invasive ventilation who developed VAP, with evaluation of admission and ventilation causes, isolation of causative organisms, and study of used antibiotics and ventilation modes. Statistical analysis Data were statistically analyzed using the SPSS software for Windows (IBM SPSS Statistics 21.0). Results It is a statistics based study aimed to trace infection incidence in national hospital ICUs. Among 222 admitted patients, only 38.4% fulfilled the criteria of VAP. Admission was because of cardiovascular impairment, cardiac arrest, respiratory failure, or head trauma. The ventilation mode at VAP time was assisted control (75%) and synchronized intermittent mandatory ventilation (25%). The minimum intubation period was 7 days, whereas the maximum period was 37 days. Isolated organisms were Pseudomonas (37.5%), Klebsiella (25%), Staphylococcus (20.8%), and methicillin-resistant Staphylococcus aureus (4.2%). The antibiotics used were amikacin, imipenem, vancomycin, levofloxacin, ceftazidime, and teicoplanin (29, 25, 21, 12.5, 8.3, and 4.2%, respectively). The minimum period of antibiotic used was 5 days, whereas the maximum period was 35 days. The highest incidence of VAP occurred in February, whereas the lowest incidence occurred in July. Conclusion The incidence of VAP is still high and varies according to the intubation cause and period, and the underlying morbidity. More efforts must be made to prevent, diagnose, and manage infection early and properly to reduce patient suffering and to reduce the burden on the serving hospitals.
引用
收藏
页码:258 / 266
页数:9
相关论文
共 50 条
  • [1] Incidence of ventilator-associated pneumonia: Egyptian study
    Reham M. Elkolaly
    Hoda M. Bahr
    Basem I. El-Shafey
    Ahmed S. Basuoni
    Eman H. Elber
    Egyptian Journal of Bronchology, 2019, 13 : 258 - 266
  • [2] Ventilator-Associated Pneumonia
    Li Bassi, Gianluigi
    Ferrer, Miguel
    Daniel Marti, Joan
    Comaru, Talitha
    Torres, Antoni
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 35 (04) : 469 - 481
  • [3] Incidence of Ventilator-Associated Pneumonia and its Bacterial Characterization - Intervention Based Prospective Study
    Ramakrishnan, Kalaivani
    Jahagirdar, Sameera N.
    Ravisankar, M.
    Seetha, K.
    GLOBAL JOURNAL OF MEDICAL PHARMACEUTICAL AND BIOMEDICAL UPDATE, 2023, 18 (27):
  • [4] Reduction in the Incidence of Ventilator-Associated Pneumonia: A Multidisciplinary Approach
    Arroliga, Alejandro C.
    Pollard, Claire L.
    Wilde, Callie D.
    Pellizzari, Shad J.
    Chebbo, Ahmad
    Song, Juhee
    Ordner, Joann
    Cormier, Stacy
    Meyer, Tricia
    RESPIRATORY CARE, 2012, 57 (05) : 688 - 696
  • [5] Is Zero Ventilator-Associated Pneumonia Achievable? Practical Approaches to Ventilator-Associated Pneumonia Prevention
    Guillamet, Cristina Vazquez
    Kollef, Marin H.
    CLINICS IN CHEST MEDICINE, 2018, 39 (04) : 809 - +
  • [6] A study of ventilator-associated pneumonia: Incidence, outcome, risk factors and measures to be taken for prevention
    Gadani, Hina
    Vyas, Arun
    Kar, Akhya Kumar
    INDIAN JOURNAL OF ANAESTHESIA, 2010, 54 (06) : 535 - 540
  • [7] Ventilator-associated pneumonia in adults: a narrative review
    Papazian, Laurent
    Klompas, Michael
    Luyt, Charles-Edouard
    INTENSIVE CARE MEDICINE, 2020, 46 (05) : 888 - 906
  • [8] Incidence, temporal trend and factors associated with ventilator-associated pneumonia in mainland China: a systematic review and meta-analysis
    Ding, Chengyi
    Zhang, Yuelun
    Yang, Zhirong
    Wang, Jing
    Jin, Aoming
    Wang, Weiwei
    Chen, Ru
    Zhan, Siyan
    BMC INFECTIOUS DISEASES, 2017, 17
  • [9] INCIDENCE, ETIOLOGY AND OUTCOME OF VENTILATOR-ASSOCIATED PNEUMONIA IN PATIENTS WITH PERCUTANEOUS TRACHEOTOMY
    Turkovic, Tihana Magdic
    Obraz, Melanija
    Glogoski, Milana Zlatic
    Juranic, Ida
    Bodulica, Bruna
    Kovacic, Josipa
    ACTA CLINICA CROATICA, 2017, 56 (01) : 99 - 109
  • [10] A Study of Profile of Ventilator-associated Pneumonia in Children in Punjab
    Sharma, Harsh
    Singh, Daljit
    Pooni, Puneet
    Mohan, Urmil
    JOURNAL OF TROPICAL PEDIATRICS, 2009, 55 (06) : 393 - 395